Yale Interdisciplinary Bioengineering Training Grant for Diabetes Research
耶鲁大学糖尿病研究跨学科生物工程培训补助金
基本信息
- 批准号:8730154
- 负责人:
- 金额:$ 28.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-04 至 2018-09-03
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): We propose the development of an interdisciplinary training program to prepare bioengineers for careers as independent researchers in diabetes. The long-term goal of this program is to foster the career development of biomedical engineers in interdisciplinary research related to diabetes. This program will build on Yale's considerable experience in the training of biomedical engineers, which will be coupled with world-leading programs in diabetes research. This application requests postdoctoral stipends for five postdoctoral (MD, PhD, or MD/PhD) fellows per year. This request is based on several factors: 1) The ongoing critical need for bioengineering scientists dedicated to studying diabetes. 2) The expanded opportunities afforded by our interdisciplinary training faculty. 3) The increase in the number of medical residents with engineering backgrounds. 4) The high quality of biomedical engineers applying to Yale postdoctoral programs. Our experience in interdisciplinary training indicates that three or more years of research training are needed for fellows to develop the skills needed for independent research. We believe a program specifically dedicated to introducing engineers to cutting-edge, interdisciplinary research in diabetes will lead to the development of scientists ready to build impactful research programs in diabetes. This program will have several key components: (1) Recruitment of bioengineering postdoctoral fellows with interests in diabetes. (2) Matching fellows with superb research mentors. (3) Participation of fellows in research projects with co-mentors in bioengineering and diabetes research. (4) Participation in a core didactic research curriculum. (5) Critical and rigorous scholar and program evaluation. (6) Establishment of a career guidance program. While enrolled in the program, postdoctoral fellows will have 80% of their time specifically dedicated to research, and support will be provided for 3 years. The focus of this program will be on bioengineering training,
which has been identified as an area where diabetes scientists are greatly needed. To achieve these goals, we will take advantage of several established programs at Yale specifically designed for training in diabetes. Potential mentors have good NIH support and a proven record of training fellows in diabetes or biomedical engineering. Please see the required T32-related supporting tables. Table 1 lists participating departments; Table 2 lists mentors and rank; Table 3 lists mentor department training programs; Table 4 lists mentor grant support; Table 5 lists mentor trainees over the past 10 years; Table 8 lists post- doctoral applicants for fellowships over the past 5 years. It is anticipated that this program will lead to the training of exceptional
bioengineers, who will embark on promising careers focusing on interdisciplinary diabetes research.
描述(由申请人提供):我们建议开发一个跨学科培训计划,为生物工程师作为糖尿病独立研究人员的职业做好准备。该项目的长期目标是促进生物医学工程师在糖尿病相关跨学科研究中的职业发展。该项目将以耶鲁大学在生物医学工程师培训方面的丰富经验为基础,并与世界领先的糖尿病研究项目相结合。该申请要求每年为五名博士后(MD、PhD 或 MD/PhD)研究员提供博士后津贴。这一要求基于以下几个因素:1) 对致力于研究糖尿病的生物工程科学家的持续迫切需求。 2) 我们的跨学科培训教师提供了更多的机会。 3)具有工程背景的住院医师数量增加。 4)申请耶鲁大学博士后项目的生物医学工程师素质较高。我们在跨学科培训方面的经验表明,研究员需要三年或更长的研究培训才能培养独立研究所需的技能。我们相信,专门致力于向工程师介绍糖尿病领域前沿、跨学科研究的项目将有助于培养科学家,为建立有影响力的糖尿病研究项目做好准备。该项目将有几个关键组成部分:(1)招募对糖尿病感兴趣的生物工程博士后。 (2)为研究员匹配优秀的研究导师。 (3) 研究员与共同导师一起参与生物工程和糖尿病研究的研究项目。 (4) 参与核心教学研究课程。 (5)批判性、严格的学者和项目评价。 (六)建立就业指导方案。加入该计划后,博士后将有 80% 的时间专门致力于研究,并将提供为期 3 年的支持。该计划的重点是生物工程培训,
这已被确定为非常需要糖尿病科学家的领域。为了实现这些目标,我们将利用耶鲁大学专门为糖尿病培训而设计的几个既定项目。潜在的导师拥有美国国立卫生研究院的良好支持,并且拥有糖尿病或生物医学工程培训研究员的良好记录。请参阅所需的T32相关支持表。表1列出了参与部门;表2列出导师及级别;表3列出了导师部门的培训计划;表 4 列出了导师资助支持;表5列出了过去10年的导师学员;表8列出了过去5年申请奖学金的博士后。预计该计划将培训杰出人才
生物工程师,他们将开始专注于跨学科糖尿病研究的有前途的职业生涯。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
W. Mark Saltzman其他文献
Next generation triplex-forming PNAs for site-specific genome editing of the F508del CFTR mutation
用于 F508del CFTR 突变位点特异性基因组编辑的下一代三链形成肽核酸
- DOI:
10.1016/j.jcf.2024.07.009 - 发表时间:
2025-01-01 - 期刊:
- 影响因子:6.000
- 作者:
Anisha Gupta;Christina Barone;Elias Quijano;Alexandra S. Piotrowski-Daspit;J. Dinithi Perera;Adele Riccardi;Haya Jamali;Audrey Turchick;Weixi Zao;W. Mark Saltzman;Peter M. Glazer;Marie E. Egan - 通讯作者:
Marie E. Egan
Enhanced Intratumoral Delivery of Immunomodulator Monophosphoryl Lipid A through Hyperbranched Polyglycerol–Coated Biodegradable Nanoparticles
通过超支化聚甘油涂层的可生物降解纳米颗粒增强免疫调节剂单磷酰脂质 A 在肿瘤内的递送
- DOI:
10.1016/j.jid.2024.07.019 - 发表时间:
2025-03-01 - 期刊:
- 影响因子:5.700
- 作者:
Jungsoo Chang;Kwangsoo Shin;Julia M. Lewis;Hee Won Suh;Joohyung Lee;William Damsky;Suzanne Xu;Marcus Bosenberg;W. Mark Saltzman;Michael Girardi - 通讯作者:
Michael Girardi
436 EFFECT OF SURVIVIN SIRNA AND VEGF SIRNA COMPLEXED IN NANOPARTICLES ON BLADDER CANCER CELLS AND UROTHELIAL TISSUES
- DOI:
10.1016/j.juro.2010.02.507 - 发表时间:
2010-04-01 - 期刊:
- 影响因子:
- 作者:
Alexander Saltzman;Kim Woodrow;Marcia A. Wheeler;Avanti Verma;W. Mark Saltzman;Robert M. Weiss - 通讯作者:
Robert M. Weiss
1358 NANOPARTICLE DELIVERY OF THE HISTONE DEACETYLASE INHIBITOR PXD101 FACILITATES BLADDER CANCER CELL UPTAKE AND CYTOTOXICITY
- DOI:
10.1016/j.juro.2011.02.1180 - 发表时间:
2011-04-01 - 期刊:
- 影响因子:
- 作者:
Hristos Z. Kaimakliotis;Darryl T. Martin;Christopher J. Hoimes;Christopher C. Cheng;Jingchun Liu;Wm. Kevin Kelly;Gregory N. Tew;W. Mark Saltzman;Robert M. Weiss - 通讯作者:
Robert M. Weiss
emIn utero/em delivery of miRNA induces epigenetic alterations and corrects pulmonary pathology in congenital diaphragmatic hernia
宫内 emin 递送 miRNA 可诱导表观遗传改变并纠正先天性膈疝中的肺部病理
- DOI:
10.1016/j.omtn.2023.04.018 - 发表时间:
2023-06-13 - 期刊:
- 影响因子:6.100
- 作者:
Sarah J. Ullrich;Nicholas K. Yung;Tory J. Bauer-Pisani;Nathan L. Maassel;Mary Elizabeth Guerra;Mollie Freedman-Weiss;Samantha L. Ahle;Adele S. Ricciardi;Maor Sauler;W. Mark Saltzman;Alexandra S. Piotrowski-Daspit;David H. Stitelman - 通讯作者:
David H. Stitelman
W. Mark Saltzman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('W. Mark Saltzman', 18)}}的其他基金
Engineering of Polymeric Particles for Fetal Therapy
用于胎儿治疗的聚合物颗粒工程
- 批准号:
10586282 - 财政年份:2023
- 资助金额:
$ 28.19万 - 项目类别:
Yale Interdisciplinary Bioengineering Training Grant for Diabetes Research
耶鲁大学糖尿病研究跨学科生物工程培训补助金
- 批准号:
8928174 - 财政年份:2013
- 资助金额:
$ 28.19万 - 项目类别:
Yale Interdisciplinary Bioengineering Training Grant for Diabetes Research
耶鲁大学糖尿病研究跨学科生物工程培训补助金
- 批准号:
8633896 - 财政年份:2013
- 资助金额:
$ 28.19万 - 项目类别:
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas
载有新型药物的纳米颗粒的 CED 可改善神经胶质瘤的治疗
- 批准号:
8232044 - 财政年份:2011
- 资助金额:
$ 28.19万 - 项目类别:
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas
载有新型药物的纳米颗粒的 CED 可改善神经胶质瘤的治疗
- 批准号:
8107039 - 财政年份:2011
- 资助金额:
$ 28.19万 - 项目类别:
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas
载有新型药物的纳米颗粒的 CED 可改善神经胶质瘤的治疗
- 批准号:
8620614 - 财政年份:2011
- 资助金额:
$ 28.19万 - 项目类别:
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas
载有新型药物的纳米颗粒的 CED 可改善神经胶质瘤的治疗
- 批准号:
8444707 - 财政年份:2011
- 资助金额:
$ 28.19万 - 项目类别:
Optimizing Revascularization by EC Transplantation
通过 EC 移植优化血运重建
- 批准号:
7633385 - 财政年份:2006
- 资助金额:
$ 28.19万 - 项目类别:
相似海外基金
The Role of CA8 in Hepatic Glucose Production and Its Prospect as Type 2 Diabetes Mellitus Treatment
CA8在肝葡萄糖生成中的作用及其治疗2型糖尿病的前景
- 批准号:
24K19287 - 财政年份:2024
- 资助金额:
$ 28.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Community-based Preconception Lifestyle Intervention to prevent Gestational Diabetes Mellitus in Women living in India
以社区为基础的孕前生活方式干预,以预防印度妇女妊娠期糖尿病
- 批准号:
494564 - 财政年份:2023
- 资助金额:
$ 28.19万 - 项目类别:
Operating Grants
Linoleic acid-derived oxylipin species and cognitive function in type 2 diabetes mellitus
亚油酸衍生的氧脂素种类与 2 型糖尿病的认知功能
- 批准号:
495437 - 财政年份:2023
- 资助金额:
$ 28.19万 - 项目类别:
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
- 批准号:
23K08326 - 财政年份:2023
- 资助金额:
$ 28.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Therapeutic efficacy of dapagliflozin, a selective inhibitor of sodium–glucose co-transporter type 2, for chronic heart failure in Japanese patients with type 2 diabetes mellitus
选择性钠抑制剂达格列净的治疗效果
- 批准号:
23K06224 - 财政年份:2023
- 资助金额:
$ 28.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pathophysiological analysis of the beta cell volume change elicited by pregnancy and gestational diabetes mellitus in Japanese pregnant women
日本孕妇妊娠和妊娠糖尿病引起的β细胞体积变化的病理生理学分析
- 批准号:
23K08020 - 财政年份:2023
- 资助金额:
$ 28.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of CXCL10-CXCR3 axis in the compounding effects of diabetes mellitus in periodontitis
CXCL10-CXCR3轴在糖尿病牙周炎复合作用中的作用
- 批准号:
10740433 - 财政年份:2023
- 资助金额:
$ 28.19万 - 项目类别:
The Study of the Association between Gestational Diabetes Mellitus and Mental Health during Pregnancy in Japanese Women
日本女性妊娠期糖尿病与孕期心理健康关系的研究
- 批准号:
23K10101 - 财政年份:2023
- 资助金额:
$ 28.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Personalized diet therapy useful for glycemic control and quality of life in patients with type 1 diabetes mellitus
个性化饮食疗法有助于 1 型糖尿病患者的血糖控制和生活质量
- 批准号:
23K10809 - 财政年份:2023
- 资助金额:
$ 28.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidating the Pathophysiology of Gestational Diabetes Mellitus
阐明妊娠糖尿病的病理生理学
- 批准号:
10738361 - 财政年份:2023
- 资助金额:
$ 28.19万 - 项目类别:














{{item.name}}会员




